Caracterización y variabilidad de los informes de evaluación de medicamentos en la página web del grupo GENESIS de la SEFH

To analyse the assessment reports published on the GENESIS webpage (Group for Innovation, Assessment, Standardisation and Research in the Selection of Drugs) and assess the variability of the group's proposals to include drugs in the Formulary. METHOD: We analysed reports...

Full description

Bibliographic Details
Main Authors: Ortega-Eslava, A. (Ana), Puigventos, F. (Francesc), Santos-Ramos, B. (B.), Calderon-Hernaz, B. (B.), Vilanova-Bolto, M. (M.)
Format: info:eu-repo/semantics/article
Language:spa
Published: Elsevier 2012
Subjects:
Online Access:https://hdl.handle.net/10171/22444
_version_ 1793400197661851648
author Ortega-Eslava, A. (Ana)
Puigventos, F. (Francesc)
Santos-Ramos, B. (B.)
Calderon-Hernaz, B. (B.)
Vilanova-Bolto, M. (M.)
author_facet Ortega-Eslava, A. (Ana)
Puigventos, F. (Francesc)
Santos-Ramos, B. (B.)
Calderon-Hernaz, B. (B.)
Vilanova-Bolto, M. (M.)
author_sort Ortega-Eslava, A. (Ana)
collection DSpace
description To analyse the assessment reports published on the GENESIS webpage (Group for Innovation, Assessment, Standardisation and Research in the Selection of Drugs) and assess the variability of the group's proposals to include drugs in the Formulary. METHOD: We analysed reports published by hospitals on the GENESIS webpage between 2004 and 2007. Data were collected on drugs and indications, ATC group, open or restricted access publications, hospital, and publication date. We drafted a questionnaire that would measure to what extent to what extent the 9-section model recommended by GENESIS was included in each report. For drugs with two or more reports, we analysed whether the recommendation coincided and the possible cause in the event of conflict. RESULTS: We analysed 416 reports corresponding to 185 different drug indications. 93% included 6 or more of the recommended sections, a number which increased over time. The most frequently included sections were: approved indications (92%), mechanism of action (95%), and references (86%) (percentages from 2007). Sections which had an increasing but lower percentage were: differential characteristics (60%), literature search method (40%) and conclusions with a summary of efficacy, safety and cost data (52%). 73% of which had definite recommendations, which coincided for 42 out of the 67 drugs with more than one recommendation report. CONCLUSIONS: The work carried out by the GENESIS group has enabled Spanish hospitals to share their drug assessment reports and making them more complete, although there are still some aspects that can be improved.
format info:eu-repo/semantics/article
id oai:dadun.unav.edu:10171-22444
institution Universidad de Navarra
language spa
publishDate 2012
publisher Elsevier
record_format dspace
spelling oai:dadun.unav.edu:10171-224442020-03-03T11:27:22Z Caracterización y variabilidad de los informes de evaluación de medicamentos en la página web del grupo GENESIS de la SEFH Ortega-Eslava, A. (Ana) Puigventos, F. (Francesc) Santos-Ramos, B. (B.) Calderon-Hernaz, B. (B.) Vilanova-Bolto, M. (M.) Drug assessment Pharmacy and therapeutics commission Pharmacists To analyse the assessment reports published on the GENESIS webpage (Group for Innovation, Assessment, Standardisation and Research in the Selection of Drugs) and assess the variability of the group's proposals to include drugs in the Formulary. METHOD: We analysed reports published by hospitals on the GENESIS webpage between 2004 and 2007. Data were collected on drugs and indications, ATC group, open or restricted access publications, hospital, and publication date. We drafted a questionnaire that would measure to what extent to what extent the 9-section model recommended by GENESIS was included in each report. For drugs with two or more reports, we analysed whether the recommendation coincided and the possible cause in the event of conflict. RESULTS: We analysed 416 reports corresponding to 185 different drug indications. 93% included 6 or more of the recommended sections, a number which increased over time. The most frequently included sections were: approved indications (92%), mechanism of action (95%), and references (86%) (percentages from 2007). Sections which had an increasing but lower percentage were: differential characteristics (60%), literature search method (40%) and conclusions with a summary of efficacy, safety and cost data (52%). 73% of which had definite recommendations, which coincided for 42 out of the 67 drugs with more than one recommendation report. CONCLUSIONS: The work carried out by the GENESIS group has enabled Spanish hospitals to share their drug assessment reports and making them more complete, although there are still some aspects that can be improved. 2012-06-04T16:33:05Z 2012-06-04T16:33:05Z 2011 info:eu-repo/semantics/article https://hdl.handle.net/10171/22444 spa http://bit.ly/KpXH2p info:eu-repo/semantics/openAccess application/pdf Elsevier
spellingShingle Drug assessment
Pharmacy and therapeutics commission
Pharmacists
Ortega-Eslava, A. (Ana)
Puigventos, F. (Francesc)
Santos-Ramos, B. (B.)
Calderon-Hernaz, B. (B.)
Vilanova-Bolto, M. (M.)
Caracterización y variabilidad de los informes de evaluación de medicamentos en la página web del grupo GENESIS de la SEFH
title Caracterización y variabilidad de los informes de evaluación de medicamentos en la página web del grupo GENESIS de la SEFH
title_full Caracterización y variabilidad de los informes de evaluación de medicamentos en la página web del grupo GENESIS de la SEFH
title_fullStr Caracterización y variabilidad de los informes de evaluación de medicamentos en la página web del grupo GENESIS de la SEFH
title_full_unstemmed Caracterización y variabilidad de los informes de evaluación de medicamentos en la página web del grupo GENESIS de la SEFH
title_short Caracterización y variabilidad de los informes de evaluación de medicamentos en la página web del grupo GENESIS de la SEFH
title_sort caracterización y variabilidad de los informes de evaluación de medicamentos en la página web del grupo genesis de la sefh
topic Drug assessment
Pharmacy and therapeutics commission
Pharmacists
url https://hdl.handle.net/10171/22444
work_keys_str_mv AT ortegaeslavaaana caracterizacionyvariabilidaddelosinformesdeevaluaciondemedicamentosenlapaginawebdelgrupogenesisdelasefh
AT puigventosffrancesc caracterizacionyvariabilidaddelosinformesdeevaluaciondemedicamentosenlapaginawebdelgrupogenesisdelasefh
AT santosramosbb caracterizacionyvariabilidaddelosinformesdeevaluaciondemedicamentosenlapaginawebdelgrupogenesisdelasefh
AT calderonhernazbb caracterizacionyvariabilidaddelosinformesdeevaluaciondemedicamentosenlapaginawebdelgrupogenesisdelasefh
AT vilanovaboltomm caracterizacionyvariabilidaddelosinformesdeevaluaciondemedicamentosenlapaginawebdelgrupogenesisdelasefh